Exane Derivatives’s NatWest NWG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-3,714
Closed -$18.8K 651
2016
Q2
$18.8K Sell
3,714
-986
-21% -$6.91K ﹤0.01% 335
2016
Q1
$32.3K Buy
4,700
+4,643
+8,146% +$35.2K ﹤0.01% 357
2015
Q4
$541 Sell
57
-1,272
-96% -$12.9K ﹤0.01% 417
2015
Q3
$13.7K Sell
1,329
-17,846
-93% -$200K ﹤0.01% 333
2015
Q2
$229K Sell
19,175
-26,167
-58% -$304K 0.02% 201
2015
Q1
$493K Buy
45,342
+24,409
+117% +$296K 0.05% 143
2014
Q4
$273K Buy
+20,933
New +$268K 0.04% 188

Other funds holding NWG

Exane Derivatives's NWG Position: Q3 2016 in Review

Exane Derivatives sold out of NatWest (NWG) in Q3 2016, closing a stake of 3,714 shares — an estimated $18.8K sold.

Exane Derivatives first reported a position in NWG in Q4 2014 and held it in 7 quarters. The position peaked at $493K in Q1 2015. 100 funds tracked by Wall St. Rank hold NWG as of Q3 2016.

  • Exane Derivatives reported no remaining NatWest position as of Q3 2016 after selling out during the quarter.
  • Exane Derivatives sold 3,714 NatWest shares in Q3 2016, an estimated $18.8K.
  • Exane Derivatives first reported a position in NatWest in Q4 2014 and held it in 7 quarters.
  • Exane Derivatives's NatWest position peaked at $493K in Q1 2015.
  • 100 funds tracked by Wall St. Rank held NatWest as of Q3 2016.

Based on Exane Derivatives's 13F filing for Q3 2016, filed 26 Oct 2016.